Ackley D - Search Results

1

FDA and industry collaboration: Identifying opportunities to further reduce reliance on nonhuman primates for nonclinical safety evaluations.

Ackley D, Birkebak J, Blumel J, Bourcier T, de Zafra C, Goodwin A, Halpern W, Herzyk D, Kronenberg S, Mauthe R, Shenton J, Shuey D, Wange RL. Ackley D, et al. Regul Toxicol Pharmacol. 2023 Feb;138:105327. doi: 10.1016/j.yrtph.2022.105327. Epub 2022 Dec 28. Regul Toxicol Pharmacol. 2023. PMID: 36586472 Free article.

2

Reevaluating safety pharmacology respiratory studies within the ICH S7A core battery: A multi-company evaluation of preclinical utility and clinical translation.

Friedrichs GS, Abernathy MM, Ackley D, Clark M, DaSilva JK, Foley CM, Greiter-Wilke A, Henderson KA, Kremer JJ, Morimoto BH, Paglialunga S, Pugsley MK, Regan CP, Rossman EI, Segretti JA, Traebert M, Vargas HM, Wisialowski TA. Friedrichs GS, et al. Among authors: ackley d. Regul Toxicol Pharmacol. 2024 Nov;153:105706. doi: 10.1016/j.yrtph.2024.105706. Epub 2024 Sep 16. Regul Toxicol Pharmacol. 2024. PMID: 39293707

3

Human milk derived fortifiers are associated with glucose, phosphorus, and calcium derangements.

Ackley D, Yin J, D'Angio C, Meyers J, Young B. Ackley D, et al. J Perinatol. 2024 Sep;44(9):1320-1324. doi: 10.1038/s41372-024-01977-5. Epub 2024 Apr 24. J Perinatol. 2024. PMID: 38658693

4

New-Onset Anasarca in a Previously Healthy 10-year-old.

Ackley D, Eastburg L, Devanagondi R. Ackley D, et al. Pediatr Rev. 2023 May 1;44(5):283-285. doi: 10.1542/pir.2021-005264. Pediatr Rev. 2023. PMID: 37122044 No abstract available.

5

Human milk-derived fortifiers are linked with feed extension due to Hypoglycemia in infants <1250 g or <30 weeks: a matched retrospective chart review.

Ackley D, Wang H, D'Angio CT, Meyers J, Young BE. Ackley D, et al. J Perinatol. 2023 May;43(5):624-628. doi: 10.1038/s41372-023-01654-z. Epub 2023 Mar 29. J Perinatol. 2023. PMID: 36991141 Free PMC article.

6

Use of high throughput ion channel profiling and statistical modeling to predict off-target arrhythmia risk - One pharma's experience and perspective.

Watt ED, Lee T, Feng SL, Kilfoil P, Ackley D, Keefer C, Wisialowski T, Jenkinson S. Watt ED, et al. Among authors: ackley d. J Pharmacol Toxicol Methods. 2022 Nov-Dec;118:107213. doi: 10.1016/j.vascn.2022.107213. Epub 2022 Sep 7. J Pharmacol Toxicol Methods. 2022. PMID: 36084863

7

The ulam Programming Language for Artificial Life.

Ackley DH, Ackley ES. Ackley DH, et al. Artif Life. 2016 Fall;22(4):431-450. doi: 10.1162/ARTL_a_00212. Epub 2016 Nov 8. Artif Life. 2016. PMID: 27824495 Review.

8

Open-Ended Evolution: Perspectives from the OEE Workshop in York.

Taylor T, Bedau M, Channon A, Ackley D, Banzhaf W, Beslon G, Dolson E, Froese T, Hickinbotham S, Ikegami T, McMullin B, Packard N, Rasmussen S, Virgo N, Agmon E, Clark E, McGregor S, Ofria C, Ropella G, Spector L, Stanley KO, Stanton A, Timperley C, Vostinar A, Wiser M. Taylor T, et al. Among authors: ackley d. Artif Life. 2016 Summer;22(3):408-23. doi: 10.1162/ARTL_a_00210. Epub 2016 Jul 29. Artif Life. 2016. PMID: 27472417

9

Application of emerging biomarkers of acute kidney injury in development of kidney-sparing polypeptide-based antibiotics.

Burt D, Crowell SJ, Ackley DC, Magee TV, Aubrecht J. Burt D, et al. Among authors: ackley dc. Drug Chem Toxicol. 2014 Apr;37(2):204-12. doi: 10.3109/01480545.2013.834360. Epub 2013 Oct 16. Drug Chem Toxicol. 2014. PMID: 24128070

10

Bespoke physics for living technology.

Ackley DH. Ackley DH. Artif Life. 2013 Summer-Fall;19(3-4):347-64. doi: 10.1162/ARTL_a_00117. Epub 2013 Jul 26. Artif Life. 2013. PMID: 23889741

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters